Clinical history of Type 1 Diabetes with \> 5 years of duration
2-hour C-peptide level \<0.3 ng/mL after a mixed meal stimulation test
Under continuous insulin therapy, Participants have at least one of the following conditions:
1. At least one episode of documented severe hypoglycemia in the 12 months prior to enrollment;
2. Unaware hypoglycemia evaluated using the Clarke scoring system
Willing and able to conduct self-blood glucose monitoring as required, with good compliance
Voluntarily participate and sign the informed consent form
You may not be if
Uncontrolled systemic infections, including but not limited to pulmonary tuberculosis, active hepatitis, a history of positive hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (HCV-Ab), human immunodeficiency virus antibody (HIV-Ab), or Treponema pallidum antibody (TP-Ab).
History of malignancy within the past 5 years or undergoing antitumor treatment
Participation in other clinical trials in the 3 months or islet cell transplant, organ transplant, or cell therapy in the 12 months prior to enrollment
Other situations judged by the investigator as unsuitable for participation in the trial